BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37819742)

  • 1. METTL3-Mediated RNA m6A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2.
    Lin Y; Luo G; Liu Q; Yang R; Sol Reinach P; Yan D
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):18. PubMed ID: 37819742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
    Zhang G; Li X; Huang X
    Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
    Huang X; Yang Z; Li Y; Long X
    Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
    Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
    Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
    Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
    Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
    Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.
    Wu Z; Lin Y; Wei N
    Cancer Sci; 2023 Jan; 114(1):129-141. PubMed ID: 36086906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
    Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
    Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
    J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 Deletion Impairs Retinal Endothelial Cell Migration Through Downregulation of VEGF-A/VEGFR-2 and MMP14.
    Lin Y; Li L; Liu J; Zhao X; Ye J; Reinach PS; Qu J; Yan D
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5431-5440. PubMed ID: 30452596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.
    Zhou Y; Jiang R; Jiang Y; Fu Y; Manafhan Y; Zhu J; Jia E
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
    Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
    J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.